---
figid: PMC2645085__zlj9990981080002
figtitle: The PI3K/Akt/mTOR pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2645085
filename: zlj9990981080002.jpg
figlink: /pmc/articles/PMC2645085/figure/f2/
number: F2
caption: Schematic representation of the PI3K/Akt/mTOR pathway. Binding of insulin
  or IGF to transmembrane receptors leads to activation mTOR via PI3K and Akt. Activation
  of mTOR promotes protein synthesis, cell growth, and cytoskeletal modeling, important
  factors stimulating malignant progression and spread. A possible mechanism of tumor
  cell resistance to mTOR inhibition in some tumor types may be the abrogation of
  negative feedback on the PI3K/Akt/mTOR pathway by S6K1, a target protein of mTOR.
  IGF, insulin-like growth factor; IRS, insulin receptor substrate; PI3K, phosphatidylinositol
  3-kinase; Akt, also known as protein kinase B; mTOR, mammalian target of rapamycin;
  S6K1, ribosomal S6 kinase 1; 4EBP1, eukaryotic translation initiation factor 4E
  binding protein.
papertitle: Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory
  Metastatic Pancreatic Cancer.
reftext: Brian M. Wolpin, et al. J Clin Oncol. 2009 Jan 10;27(2):193-198.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.922513
figid_alias: PMC2645085__F2
figtype: Figure
redirect_from: /figures/PMC2645085__F2
ndex: d8ddd199-dea4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2645085__zlj9990981080002.html
  '@type': Dataset
  description: Schematic representation of the PI3K/Akt/mTOR pathway. Binding of insulin
    or IGF to transmembrane receptors leads to activation mTOR via PI3K and Akt. Activation
    of mTOR promotes protein synthesis, cell growth, and cytoskeletal modeling, important
    factors stimulating malignant progression and spread. A possible mechanism of
    tumor cell resistance to mTOR inhibition in some tumor types may be the abrogation
    of negative feedback on the PI3K/Akt/mTOR pathway by S6K1, a target protein of
    mTOR. IGF, insulin-like growth factor; IRS, insulin receptor substrate; PI3K,
    phosphatidylinositol 3-kinase; Akt, also known as protein kinase B; mTOR, mammalian
    target of rapamycin; S6K1, ribosomal S6 kinase 1; 4EBP1, eukaryotic translation
    initiation factor 4E binding protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - IRSp53
  - IleRS
  - chico
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - S6k
  - Mtor
  - Tor
  - Thor
  - IGF1
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - RPS6KB1
  - MTOR
  - EIF4EBP1
---
